Table 3.
Factor | Hazard ratio (95% confidence interval) | P-value |
---|---|---|
Demographics | ||
Age | 1.01 (0.98–1.03) | .685 |
Male gender | 1.25 (0.67–2.35) | .483 |
Underlying liver disease | ||
Hepatitis C virus infection with or without alcoholic liver disease | 1.91 (1.17–3.14) | .010* |
Autoimmune liver disease | 1.01 (0.46–2.21) | .985 |
Alcoholic liver disease | 1.34 (0.77–2.33) | .307 |
Patient's location before undergoing liver transplantation | ||
Home | Reference | |
Hospital ward | 0.96 (0.55–1.67) | |
Intensive care unit (without ventilation) | 0.42 (0.13–1.36) | |
Intensive care unit (with ventilation) | 0.36 (0.09–1.50) | |
Donor/graft factors | ||
Deceased donor (brain death) | Reference | |
Deceased donor (cardiac death) | 1.50 (0.78–2.89) | |
Live donor | 1.51 (0.47–4.86) | |
Donor age | 1.01 (0.99–1.02) | .267 |
Cold ischemia time | 1.00 (0.99–1.00) | .722 |
Complications | ||
Malnutrition | 0.83 (0.42–1.63) | .586 |
Diabetes mellitus | 1.44 (0.71–2.91) | .317 |
Debility | 0.66 (0.24–1.82) | .424 |
Infection | 0.33 (0.08–1.33) | .118 |
Surgical complications | 0.99 (0.58–1.72) | .981 |
Length of stay | ||
Total hospitalization post–liver transplantation | 0.99 (0.97–1.00) | .064 |
Stay in intensive care post–liver transplantation | 0.92 (0.85–0.99) | .028* |
Other factors | ||
Model for End-Stage Liver Disease score | 0.97 (0.95–1.00) | .050 |
Additional consultative services | 0.97 (0.79–1.19) | .771 |
Statistically significant.